Position in JNJ
as of Mar 31, 2026
· filed May 6, 2026
Position Value
$3,528,649,542
+$736,031,898 QoQ
Shares Held
14,435,647
+7.0% QoQ
Ownership
0.600%
of shares outstanding
% of Portfolio
1.20%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 43.48843526029696.ToString("F0")%
Shared 1.5161911343495724.ToString("F0")%
None 54.99537360535347.ToString("F0")%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Derivatives in JNJ
reported options exposure · as of Mar 31, 2020CallValue
$63,466
CallShares
484
PutValue
$23,340
PutShares
178
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026DEUTSCHE BANK AG\ holds $16,087,469,920 across 16 Drug Manufacturers - General names. JNJ ranks #1 (21.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
This page
|
14,435,647 | $3,528,649,542 | |
| 2 | LLY |
ELI LILLY & Co
|
3,547,772 | $3,263,134,246 | |
| 3 | AZN |
Astrazeneca PLC
|
12,129,724 | $2,392,224,162 | |
| 4 | ABBV |
AbbVie Inc.
|
9,531,362 | $2,072,975,912 | |
| 5 | MRK |
Merck & Co., Inc.
|
12,540,774 | $1,508,529,698 | |
| 6 | PFE |
Pfizer Inc
|
31,428,987 | $882,525,946 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
6,222,328 | $867,205,844 | |
| 8 | AMGN |
Amgen Inc
|
2,255,759 | $793,688,795 |
All Filings in JNJ
Export CSV
27 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,528,649,542 | 14,435,647 | Shares | Defined | 2026-05-06 | |
| 2025-12-31 | $2,792,617,644 | 13,494,166 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $2,575,227,540 | 13,888,618 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $2,420,419,363 | 15,845,626 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $2,536,998,086 | 15,297,866 | Shares | Defined | 2025-05-09 | |
| 2024-12-31 | $2,004,449,532 | 13,860,113 | Shares | Defined | 2025-06-30 | |
| 2024-09-30 | $2,311,507,960 | 14,263,285 | Shares | Sole | 2025-06-26 | |
| 2024-06-30 | $2,154,838,334 | 14,743,010 | Shares | Sole | 2025-06-12 | |
| 2024-03-31 | $2,230,362,720 | 14,099,265 | Shares | Sole | 2025-06-02 | |
| 2023-12-31 | $2,027,474,682 | 12,935,273 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $1,877,189,799 | 12,052,583 | Shares | Defined | 2023-11-24 | |
| 2023-06-30 | $2,375,934,650 | 14,354,366 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $2,363,934,605 | 15,251,191 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $2,691,822,015 | 15,238,166 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $2,526,447,665 | 15,465,522 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $2,721,250,301 | 15,330,124 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $2,727,579,968 | 15,390,058 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $2,944,900,416 | 17,214,593 | Shares | Defined | 2022-02-16 | |
| 2021-09-30 | $2,643,097,852 | 16,365,931 | Shares | Defined | 2021-11-04 | |
| 2021-06-30 | $2,674,456,529 | 16,234,409 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $2,568,729,354 | 15,629,628 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $2,419,635,178 | 15,374,477 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $2,232,684,717 | 14,996,539 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $1,987,780,432 | 14,134,825 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $1,865,391,773 | 14,225,515 | Shares | Defined | 2020-05-14 | |
| 2020-03-31 | $23,340 | 178 | Put | Defined | 2020-05-14 | |
| 2020-03-31 | $63,466 | 484 | Call | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||